The Vanguard Group, Inc. has recently announced that it has increased stake in ChromaDex Corporation (NASDAQ:CDXC) by 2.26%. After grabbing 2.21 million shares, the institutional investor is now in possession of 48853.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 2.97% having worth around $3.81 million. Moreover, Geode Capital Management LLC increased its share by 4588.0 to have a control over 0.55 million shares.
ChromaDex Corporation (CDXC) concluded trading on 01/12/23 at a closing price of $2.04, with 0.47 million shares of worth about $0.96 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 14.61% during that period and on Thursday the price saw a gain of about 2.00%. Currently the company’s common shares owned by public are about 68.34M shares, out of which, 40.78M shares are available for trading.
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 5 analysts are covering the CDXC stock and their offered price forecasts bring an average price target of $5.87. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $10.00 and could fall to a lowest price of $2.10. The stock’s current price level is 66.34% above of average price target set by the analysts, while a rise to estimated low would result in gain of 2.86% for the stock. However, touching the estimated high of $10.00 would mean a gain of 79.6% for the stock.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 4 times over the past 12 months. They bought 1,125,037 shares in 4 of the transactions. In 0 selling transactions, insiders dumped 0 shares.
Vanguard Total Stock Market Index, Vanguard Extended Market Index Fu, and Fidelity Extended Market Index Fu are the top 3 mutual funds which are holding stakes in ChromaDex Corporation Vanguard Total Stock Market Index is currently holding 1.76 million shares of worth totaling $3.03 million. The company recently came buying 0.37 million shares which brought its stake up to 2.37% of the company’s outstanding shares. Fidelity Extended Market Index Fu, after buying 0.3 million shares, have now control over 0.40% of the stake in the company. It holds 0.0 shares of worth $0.52 million.
ChromaDex Corporation (NASDAQ: CDXC) started trading at $2.01, above $0.01 from concluding price of the previous day. However, the stock later moved at a day high price of 2.0400, or with a gain of 2.00%. Stock saw a price change of 10.87% in past 5 days and over the past one month there was a price change of 29.11%. Year-to-date (YTD), CDXC shares are showing a performance of 21.43% which decreased to -37.23% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.15 but also hit the highest price of $3.34 during that period. The average intraday trading volume for ChromaDex Corporation shares is 252.18K. The stock is currently trading 22.93% above its 20-day simple moving average (SMA20), while that difference is up 20.24% for SMA50 and it goes to 17.50% higher than SMA200.
The Vanguard Group, Inc. acquired 2.21 million shares of ChromaDex Corporation having value of about $3.81 million. Data submitted at the U.S SEC by The Vanguard Group, Inc. revealed that the firm now holds 48853.0 shares in the company valued at close to $99660.12, or have control over 2.26% stake in the company. ChromaDex Corporation (NASDAQ: CDXC) currently have 68.34M outstanding shares and institutions hold larger chunk of about 16.70% of that. Holding of mutual funds in the company is about 28.86% while other institutional holders and individual stake holders have control over 4.85% and 11.59% of the stake respectively.
The stock has a current market capitalization of $145.55M and its 3Y-monthly beta is at 1.74. It has posted earnings per share of -$0.30 in the same period. It has Quick Ratio of 1.30 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CDXC, volatility over the week remained 5.45% while standing at 5.99% over the month.
Analysts are in expectations that ChromaDex Corporation (CDXC) stock would likely to be making an EPS of -$0.06 in the current quarter, while forecast for next quarter EPS is -$0.04 and it is -$0.14 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.08 which is -$0.04 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.13 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -23.80% while it is estimated to increase by 62.50% in next year.
Coverage by B. Riley Securities stated ChromaDex Corporation (CDXC) stock as a Neutral in their note to investors on August 11, 2022, suggesting a price target of $2.40 for the stock. On March 08, 2022, ROTH Capital Initiated their recommendations, while on October 16, 2019, Oppenheimer Initiated their ratings for the stock with a price target of $6. Stock get a Buy rating from B. Riley FBR on February 14, 2019.